Literature DB >> 9222260

Pharmacotherapy for opioid and cocaine abuse.

E A Warner1, T R Kosten, P G O'Connor.   

Abstract

The need for continued development of medications to address opioid and cocaine addiction is unequivocal. Methadone maintenance, despite its limitations, remains the best-established pharmacologic treatment for opioid dependence. Continued participation in methadone programs is associated with decreased risk of acquiring HIV infection. Clonidine alone or combined with naltrexone may be used for opioid detoxification in the office practice. At the present time, no proven pharmacologic therapy for cocaine addiction exists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222260     DOI: 10.1016/s0025-7125(05)70555-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

1.  Addressing drug abuse: policy deliberations in the great south land.

Authors:  J H Samet
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

Review 2.  Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence.

Authors:  D M Tomkins; E M Sellers
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

Review 3.  Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking.

Authors:  J Stewart
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 4.  Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.

Authors:  Jeanette M Tetrault; David A Fiellin
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

5.  Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.

Authors:  Donna M Platt; Joshua S Rodefer; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

Review 6.  Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.

Authors:  Hongyuan Chu; Guozhang Jin; Eitan Friedman; Xuechu Zhen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

Review 7.  Single versus multiple drug focus in substance abuse clinical trials research.

Authors:  Bruce J Rounsaville; Nancy M Petry; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.